BrainStorm Cell Therapeutics Inc announces topline data from its Phase 2 trial evaluating three repeated administrations of NurOwn (MSC-NTF cells), each given 2 months apart, as a treatment for progressive multiple sclerosis (MS). The study achieved the primary...
Grafting neurons grown from monkeys’ own cells into their brains relieved the debilitating movement and depression symptoms associated with Parkinson’s disease, researchers at the University of Wisconsin-Madison report, in Nature Medicine. In the study,...
An international team of scientists experimenting on patient-based cell cultures in the laboratory has clarified the cause for certain genetic forms of Parkinson’s disease, and has identified potential pharmacological treatments, they report, in Science...
